Literature DB >> 23303495

Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities.

Larissa Lutz1, Robson Souza Leão, Alex Guerra Ferreira, Dariane Castro Pereira, Caroline Raupp, Tyrone Pitt, Elizabeth Andrade Marques, Afonso Luis Barth.   

Abstract

Hypermutable (HPM) strains of Pseudomonas aeruginosa have been found at high frequencies in cystic fibrosis (CF) patients in Europe. We report the results of testing for HPM frequencies, mutator genotype, and antimicrobial resistance of P. aeruginosa strains from Brazilian CF patients. A modified disk diffusion technique was used to quantify antibiotic-resistant subpopulations of an isolate, and estimations of the frequency of mutation to rifampin resistance were determined for 705 isolates from 149 patients attending clinics in two Brazilian cities. Mutations in the mutS gene were detected by sequencing assays. We found 194 (27.5%) HPM isolates in samples from 99 (66.4%) patients. Thirty-five HPM isolates (18.0%) from 31 (31.3%) patients exhibited a high increased spontaneous mutation rate compared with controls, and eight isolates from six patients displayed a defective mutS gene. The dominant HPM population was associated with very low antibiotic resistance levels, while HPM subpopulations were generally more resistant to antimicrobials. A relatively high prevalence of HPM P. aeruginosa in CF patients was associated with surprisingly low antibiotic resistance levels, in contrast to some earlier studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303495      PMCID: PMC3592082          DOI: 10.1128/JCM.02638-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  The role of mutators in the emergence of antibiotic-resistant bacteria.

Authors:  Ian Chopra; Alexander J O'Neill; Keith Miller
Journal:  Drug Resist Updat       Date:  2003-06       Impact factor: 18.500

2.  Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair.

Authors:  J H Miller
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

Review 3.  Adaptive evolution of highly mutable loci in pathogenic bacteria.

Authors:  E R Moxon; P B Rainey; M A Nowak; R E Lenski
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

4.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

5.  Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.

Authors:  Oana Ciofu; Bente Riis; Tacjana Pressler; Henrik Enghusen Poulsen; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.

Authors:  K Senda; Y Arakawa; S Ichiyama; K Nakashima; H Ito; S Ohsuka; K Shimokata; N Kato; M Ohta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital.

Authors:  Maria Renata Gomes Franco; Hélio Hehl Caiaffa-Filho; Marcelo Nascimento Burattini; Flávia Rossi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 8.  Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.

Authors:  R B Fick; F Sonoda; D B Hornick
Journal:  Semin Respir Infect       Date:  1992-09

9.  Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion.

Authors:  Maria D Maciá; Nuria Borrell; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Authors:  Ana C Gales; Liana C Menezes; Suzane Silbert; Hélio S Sader
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

View more
  3 in total

1.  Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.

Authors:  Vanessa E Rees; Deanna S Deveson Lucas; Carla López-Causapé; Yuling Huang; Tom Kotsimbos; Jürgen B Bulitta; Murray C Rees; Adele Barugahare; Anton Y Peleg; Roger L Nation; Antonio Oliver; John D Boyce; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis.

Authors:  Mila M Almeida; Meyvianne T Freitas; Tania W Folescu; Monica C Firmida; Ana Paula D'A Carvalho-Assef; Elizabeth A Marques; Robson S Leão
Journal:  Curr Microbiol       Date:  2021-01-06       Impact factor: 2.188

3.  Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.

Authors:  Jennifer L McCurtain; Adam J Gilbertsen; Clayton Evert; Bryan J Williams; Ryan C Hunter
Journal:  J Med Microbiol       Date:  2019-01-22       Impact factor: 2.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.